Dr. Ana Maria Gonzalez-Angulo is a noted medical practitioner and researcher who focuses on breast cancer as a senior member of the Unidad de Cancerologia team in Guadalajara. She frequently treats young patients with aggressive breast cancers. She also handles complex cases involving comorbidities, as well as patients suffering from cancer while pregnant. Another focus for Dr. Ana Maria Gonzalez-Angulo is metformin, beta-blockers, and other medications that combine anticancer properties with proven safety and effectiveness.

Dr. Gonzalez-Angulo earned her MD at the Universidad del Cauca School of Health Sciences in Colombia and completed a residency in Internal Medicine at the Mount Sinai Medical Center in Miami Beach and a fellowship in Medical oncology at the Ochsner Clinic Foundation in New Orleans. Later on, she also undertook a Susan G. Komen Interdisciplinary Breast Cancer fellowship at the University of Texas MD Anderson Cancer Center. She continue her education with a master’s degree in clinical research and a doctorate in cancer cell biology, both at the University of Texas. She wrote her thesis on the topic “Basis for targeting MET activation-mediated resistance to PI3K inhibition in breast cancer,” and later directed the Clinical Research and Drug Development Section of the institution’s Department of Breast Medical Oncology.

She turned to humanities and earned a bachelors in religious sciences at the Pontificia Universidad Javeriana, School of Theology in Bogota. Followed by a master’s degree in Bioethics an a second master’s degree in Theology in the same university. Her theses focused on the topic of the religious experience of how a physician-scientist experiences God and of the ethical issues og gene editing in viable human embryos. A practicing Catholic, she has also written on how death and the afterlife are viewed across historical religions.